RxDoctor Payments Data

Elizabeth Oleary, PA

Physician Assistant · Cary, NCNPI 1639115553

Payments from drug & device makers

$18,492in general payments, 2019–2025

Across 262 payments — averaging $70.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$10K
  • Mallinckrodt Hospital Products Inc.$3K
  • Amgen$1K
  • OPKO Pharmaceuticals, LLC$745
  • AstraZeneca$568
  • Fresenius USA Marketing, Inc.$492
  • plus $2K from 17 others

What the payments were for

  • Consulting fees$3002%
  • Speaking & faculty fees$12,12266%
  • Travel & lodging$5873%
  • Food & beverage$5,26428%
  • Education$2201%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,492 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$22,254
Medicare patients
171
Services billed
384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
KerendiaFinerenone44$32,163
VeltassaPatiromer Calcium Sorbitex14$13,597
FarxigaDapagliflozin Propanediol15$12,402
JardianceEmpagliflozin15$9,644
Sevelamer Carbonate34$7,447
Cinacalcet Hcl12$4,239
Calcium Acetate15$1,561
Torsemide34$1,378
Losartan Potassium119$1,216
Famotidine72$1,155
Bumetanide16$1,047
Febuxostat13$1,043
Amlodipine Besylate76$938
Potassium Chloride18$641
Midodrine Hcl15$640

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
BayerKerendia$10,134$32,16344 claims
AstraZenecaFarxiga$568$12,40215 claims
Boehringer IngelheimJardiance$119$9,64415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Cary

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →